[2,2'-Bipyridine]-6,6'-dicarboxylic acid, 95.0%, 250mg

N-(4-Amino-2-chlorophenyl)morpholine, 95.0%, 1g

H-Orn(2-Cl-Z)-OH, 95%, 5g

9-(3-Bromophenyl)-10-phenylanthracene, 99.0%, 5g

Trimethylhexamethylene Diisocyanate (2,2,4- and 2,4,4- mixture)>97.0%(GC)500mL

2-Vinylpyridine (stabilised with tert-Butylcatechol), 95.0%, 1g

methyl bicyclo[1.1.1]pentane-1-carboxylate, 97, 100mg

4-Chloro-3-nitrobenzonitrile, 95.0%, 5g

Ethylboronic acid, 97.0%, 25g

3,4-Bis(difluoromethoxy)benzaldehyde, 95.0%, 1g

(S)-3-tert-Butoxycarbonylamino-4-methyl-pentanoic acid, 99.0%, 5g

2-Fluoro-n-(propan-2-yl)benzene-1-sulfonamide, 97%, 1g

tert-Butyl 4-(3-aminopropyl)piperidine-1-carboxylate, 95.0%, 100mg